Publications by authors named "James Knost"

Claim this Profile
M
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer.
Aparna R Parikh, Fa-Chyi Lee, Linda Yau, Han Koh, James Knost

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent.
Zöe Powis, Carin R Espenschied, Holly LaDuca, Kelly D Hagman, Tripti Paudyal, James Knost

Cancer Genet· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
Natalie Galanina, Sonali M Smith, Chuanhong Liao, Adam Petrich, Bernadette Libao, James A Knost

Br J Haematol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.
Leora Witkowski, Nancy Donini, Rebecca Byler-Dann, James A Knost, Steffen Albrecht

Fam Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Alexa B Schrock, Shuyu D Li, Garrett M Frampton, James Suh, Eduardo Braun, James Knost

J Thorac Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.
Lauren M Thorpe, Alexa B Schrock, Rachel L Erlich, Vincent A Miller, James Knost

Head Neck· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.
Muhammad Wasif Saif, James A Knost, E Gabriela Chiorean, Siva Rama Prasad Kambhampati, Danni Yu

Cancer Chemother Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
Leora Witkowski, Catherine Goudie, Pilar Ramos, Talia Boshari, Jean-Sebastien Brunet, James A Knost

Gynecol Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer.
Edward H Lin, Heinz-Josef Lenz, Mansoor N Saleh, Mary J Mackenzie, James A Knost

Cancer Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.
Manish R Sharma, Kristen Wroblewski, Blase N Polite, James A Knost, James A Wallace

Invest New Drugs· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors.
Aminah Jatoi, Gamini Soori, Nathan R Foster, Bradley K Hiatt, James A Knost

J Thorac Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.
Halla S Nimeiri, Amit M Oza, Robert J Morgan, Dezheng Huo, Laurie Elit, James A Knost

Gynecol Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small interfering RNA-directed knockdown of uracil DNA glycosylase induces apoptosis and sensitizes human prostate cancer cells to genotoxic stress.
Sai Murali Krishna Pulukuri, James A Knost, Norman Estes, Jasti S Rao

Mol Cancer Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Amy C Peterson, Helena Harlin, Theodore Karrison, Nicholas J Vogelzang, James A Knost

Invest New Drugs· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
Steven R Alberts, Hani Al-Khatib, Michelle R Mahoney, Lawerence Burgart, Peter J Cera, James A Knost

Cancer· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
Richard D Hurt, James E Krook, Ivana T Croghan, Charles L Loprinzi, Jeff A Sloan, James A Knost

J Clin Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of patients with advanced/recurrent carcinoma of cervix and vagina after neoadjuvant treatment with methotrexate, vinblastine, doxorubicin, and cisplatin with or without the addition of molgramostim, and review of the literature.
Harry J Long, Sandra Rayson, Karl C Podratz, Samir Abu-Ghazaleh, Vera Suman, James A Knost

Am J Clin Oncol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis